CWM
PRCT icon

CIBC World Markets’s Procept Biorobotics PRCT Stock Holding History

CIBC World Markets’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$373K Sell
6,474
-3,413
-35% -$193K ﹤0.01% 992
2025
Q1 		$576K Buy
9,887
+5,718
+137% +$390K ﹤0.01% 937
2024
Q4 		$336K Buy
+4,169
New +$356K ﹤0.01% 883

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

CIBC World Markets's PRCT Position: Q2 2025 in Review

CIBC World Markets reduced its Procept Biorobotics (PRCT) stake by 35% in Q2 2025, selling an estimated $193K and leaving 6,474 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #992.

CIBC World Markets first reported a position in PRCT in Q4 2024 and has held it in 3 quarters since. The position peaked at $576K in Q1 2025. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • CIBC World Markets held 6,474 shares of Procept Biorobotics worth $373K as of Q2 2025.
  • CIBC World Markets sold 3,413 Procept Biorobotics shares in Q2 2025, an estimated $193K.
  • Procept Biorobotics made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #992 holding.
  • CIBC World Markets first reported a position in Procept Biorobotics in Q4 2024 and has held it in 3 quarters since.
  • CIBC World Markets's Procept Biorobotics position peaked at $576K in Q1 2025.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.